Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.50 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.50 |
| ▸ | KDM6B | O15054 | 1/20 | 0.49 |
| ▸ | KDM4A | O75164 | 1/20 | 0.49 |
| ▸ | KDM2A | Q9Y2K7 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | CXCR4 | P61073 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | CHRM2 | P08172 | 6/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.46 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.43 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.43 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.43 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.43 |
| ▸ | MAOA | P21397 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL2202981 | 0.98 | LMNA (0.51) | HRH4HRH3KDM6BKDM4AKDM2A | |
| SCHEMBL2205452 | 0.98 | HRH4 (0.51) | HRH4HRH3KDM6BKDM4AKDM2A | |
| Hydrochloric Acid SCHEMBL2201340 | 0.97 | CYP1A2 (0.50) | HRH4HRH3KDM6BKDM4AKDM2A | |
| Hydrochloric Acid SCHEMBL15162287 | 0.97 | CYP1A2 (0.50) | HRH4HRH3KDM6BKDM4AKDM2A | |
| SCHEMBL21799800 | 0.84 | HRH4 (0.70) | HRH4HRH3LMNASMN1; SMN2CHRM2 | |
| SCHEMBL21799710 | 0.84 | HRH4 (0.70) | HRH4HRH3LMNASMN1; SMN2CHRM2 | |
| SCHEMBL21799901 | 0.84 | HRH4 (0.70) | HRH4HRH3LMNASMN1; SMN2CHRM2 | |
| SCHEMBL21799885 | 0.84 | HRH4 (0.70) | HRH4HRH3LMNASMN1; SMN2CHRM2 | |
| SCHEMBL21799810 | 0.84 | HRH4 (0.70) | HRH4HRH3LMNASMN1; SMN2CHRM2 | |
| SCHEMBL21799876 | 0.84 | HRH4 (0.70) | HRH4HRH3LMNASMN1; SMN2CHRM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7977512-B2 | Amine derivative, and production method and use thereof | KUREHA CORPORATION (JP) | 2011-07-12 | — | — | US | disclosed |
| US-20080293951-A1 | Amin Derivative, and Production Method and Use Thereof | KUREHA CORPORATION | 2008-11-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080293951-A1 | Amin Derivative, and Production Method and Use Thereof | BCAT2, BCAT1, MRPL9 | HRH4 52/4885HRH3 132/4885KDM6B 2911/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.